18 results
424B4
PCSA
Processa Pharmaceuticals Inc
29 Jan 24
Prospectus supplement with pricing info
4:15pm
. Although we initiated several recruitment programs to enroll patients in this trial, we were only able to recruit four patients. We experienced
8-K
EX-99.1
d19 ntqbm
26 Jan 22
Processa Pharmaceuticals CEO Dr. David Young Issues Letter to Shareholders Providing Outlook for 2022
8:15am
424B3
av2dylf pl
12 Apr 21
Prospectus supplement
1:44pm
S-3
6638okswm 67
2 Apr 21
Shelf registration
12:00am
- Prev
- 1
- Next